Economic evaluation of folic acid food fortification in The Netherlands

• Published in: European journal of public health Vol. 18; no. 3; pp. 270 - 274
• Main Authors: Jentink, Janneke, van de Vrie-Hoekstra, Nienke W., de Jong-van den Berg, Lolkje T. W., Postma, Maarten J.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.06.2008; Oxford Publishing Limited (England)
• Subjects: Acids; Birth defects; Children & youth; Cost analysis; Cost control; cost effectiveness analysis; Cost-Benefit Analysis; Dietary Supplements - utilization; Female; folic acid; Folic Acid - administration & dosage; Folic Acid - economics; Food; Food fortification; Food, Fortified - economics; fortified food; health care costs; Health care expenditures; Health economics; Hospital costs; Humans; International organizations; Netherlands - epidemiology; neural tube defects; Neural Tube Defects - economics; Neural Tube Defects - epidemiology; Neural Tube Defects - prevention & control; Older people; Pharmacy; Pregnancy; Pregnancy Outcome; Prenatal Nutritional Physiological Phenomena; Prevalence; Public health; Quality of life; Quality-Adjusted Life Years; Sensitivity analysis; Vitamin B; Womens health; Netherlands; fortified food; neural tube defects; cost effectiveness analysis; folic acid; health care costs
• ISSN: 1101-1262; 1464-360X
• DOI: 10.1093/eurpub/ckm129

Background: Folic acid intake before and during pregnancy reduces neural tube defects (NTD). Therefore, several countries have enriched bulk food with folic acid resulting in a 26–48% decrease in the prevalence of NTDs. In 2000, the Dutch Health Council advised against folic acid enrichment based on literature research; yet formal cost-effectiveness information was absent. We designed our study to estimate cost-effectiveness of folic acid food fortification in the Netherlands. Method: Prevalence of NTD at birth, life-time costs of care, and folic acid fortification costs were estimated using Dutch registrations, Dutch guidelines for costing, (inter)national literature and expert opinions. Both net cost per discounted life year gained and net cost per discounted quality adjusted life year (QALY) gained were estimated for the base case and sensitivity analyses. Results: In the base case and most sensitivity analyses, folic acid enrichment was estimated to be cost-saving. Bulk food fortification with folic acid remains cost-effective as long as enrichment costs do not exceed €5.5 million (threshold at €20 000 per QALY). Conclusion: Our model suggests that folic acid fortification of bulk food to prevent cases of NTD in newborns might be a cost-saving intervention in the Netherlands. Additionally, besides the evidence that folic acid reduces the number of NTDs, there are indications that folic acid is associated with the prevention of other birth defects, cardiovascular diseases and cancer. Our model did not yet include these possibly beneficial effects.